Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Zenas BioPharma, Inc. (ZBIO) had Free Cash Flow per Share of $-9.08 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$5.00M |
|
$-156.99M |
|
-- |
|
$5.00M |
|
$168.89M |
|
$-163.89M |
|
$7.33M |
|
$-156.56M |
|
$-156.56M |
|
$-156.99M |
|
$-156.99M |
|
$-156.99M |
|
$-156.99M |
|
$-163.89M |
|
$-163.75M |
|
13.20M |
|
13.20M |
|
$-11.89 |
|
$-11.89 |
|
| Balance Sheet Financials | |
$355.92M |
|
$0.18M |
|
$14.04M |
|
$369.97M |
|
$57.29M |
|
-- |
|
$0.22M |
|
$57.51M |
|
$312.46M |
|
$312.46M |
|
$312.46M |
|
41.79M |
|
| Cash Flow Statement Financials | |
$-119.67M |
|
$-30.55M |
|
$412.96M |
|
$56.94M |
|
$319.83M |
|
$262.89M |
|
$10.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3277.76% |
|
-3277.76% |
|
-3275.02% |
|
-3131.18% |
|
-3139.76% |
|
$-119.81M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-50.24% |
|
-50.24% |
|
-42.43% |
|
-50.24% |
|
$7.48 |
|
|
Free Cash Flow per Share |
$-9.08 |
$-9.07 |
|